A large meta-analysis has cast a shadow over cefepime, one of medicine's most trusted hospital antibiotics, suggesting it may be associated with a meaningfully higher risk of death than its closest alternatives. The finding does not indict the drug so much as it illuminates the ancient tension between a remedy's power and its peril — the same potency that kills bacteria may, in the wrong measure, harm the patient. Researchers are not calling for abandonment but for wisdom: better dosing, deeper inquiry, and perhaps new tools to help clinicians walk the narrow path between underdose and overdos
Meta-analysis links cefepime antibiotic to higher mortality risk in hospitalized adults
778 deaths occurred among 11,726 patients receiving cefepime in the analyzed trials, representing a higher mortality rate than comparison antibiotics.